Neoadjuvant chemotherapy for colon cancer: A systematic review and meta-analysis of randomized controlled trials
Authors:
- Mariana Macambira NoronhaMNMariana Macambira Noronha
- Luiz F. Costa AlmeidaLALuiz F. Costa Almeida
- Anelise Poluboiarinov CappellaroACAnelise Poluboiarinov Cappellaro
- Luís Felipe Leite da SilvaLSLuís Felipe Leite da Silva
- Lucas Diniz da ConceiçãoLCLucas Diniz da Conceição
- Junior Samuel Alonso de MenezesJMJunior Samuel Alonso de Menezes
- Renata D.’aLpino PeixotoRenata D.’aLpino Peixoto
- 25 April 2025
- journal article
- research article
- Published by Elsevier in European Journal of Cancer
- Vol. 222, 115476
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- 552P Baseline imaging biomarkers to predict outcomes in locally advanced colon cancer (LACC): Data from the FOxTROT international randomised-controlled trialAnnals of Oncology, 2024
- 503O Neoadjuvant nivolumab (nivo) plus relatlimab (rela) in MMR-deficient colon cancer: Results of the NICHE-3 studyAnnals of Oncology, 2024
- Neoadjuvant Immunotherapy in Locally Advanced Mismatch Repair–Deficient Colon CancerNew England Journal of Medicine, 2024
- Diagnostic accuracy of CT for local staging of colon cancer: A nationwide study in the NetherlandsEuropean Journal of Cancer, 2023
- The American Society of Colon and Rectal Surgeons Clinical Practice Guidelines for the Management of Colon CancerDiseases of the Colon & Rectum, 2021
- Localised colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upAnnals of Oncology, 2020
- Neoadjuvant immunotherapy leads to pathological responses in MMR-proficient and MMR-deficient early-stage colon cancersNature Medicine, 2020
- Adjuvant Chemotherapy and Risk of Gastrointestinal, Hematologic, and Cardiac Toxicities in Elderly Patients With Stage III Colon CancerAmerican Journal of Clinical Oncology, 2012
- Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trialThe Lancet, 2008
- Tumor Progression While on ChemotherapyAnnals of Surgery, 2004